Literature DB >> 20499285

Tumor necrosis factor alpha gene -376 polymorphism and susceptibility to multiple sclerosis: an Egyptian study.

Mona Abd el Fattah Nada1, Dalia Ahmed Labib.   

Abstract

Tumor necrosis factor alpha, a proinflammatory cytokine, plays an important role in the clinical activity of relapsing-remitting multiple sclerosis and the development of progression. Dysregulation in the expression of tumor necrosis factor gene had been suggested in the pathogenesis of multiple sclerosis. Our aim was to investigate the relationship between tumor necrosis factor α-376 polymorphism with disease susceptibility and course of multiple sclerosis in Egyptian patients. Polymerase chain reaction and restriction fragment length polymorphism were carried out on 36 primary progressive multiple sclerosis patients, 36 age- and sex-matched remitting relapsing multiple sclerosis patients (diagnosed according to McDonald's Diagnostic criteria) and 30 age- and sex-matched healthy controls. The GG genotype and the guanine allele (G) were detected significantly more often in the primary progressive (p = 0.02; p = 0.004, respectively) and remitting relapsing (p = 0.015; p = 0.024, respectively) multiple sclerosis groups as compared with the healthy control group. The G allele in the examined position in tumor necrosis factor alpha might have a role as regards susceptibility in both remitting relapsing and primary progressive multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20499285     DOI: 10.1007/s11481-010-9220-0

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  32 in total

1.  A population-based case-control study of the tumor necrosis factor alpha-308 polymorphism in multiple sclerosis.

Authors:  D Wingerchuk; Q Liu; J Sobell; S Sommer; B G Weinshenker
Journal:  Neurology       Date:  1997-08       Impact factor: 9.910

2.  Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiple sclerosis.

Authors:  B G Weinshenker; D M Wingerchuk; Q Liu; A S Bissonet; D J Schaid; S S Sommer
Journal:  Neurology       Date:  1997-08       Impact factor: 9.910

Review 3.  Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system.

Authors:  Mark Pickering; Derval Cumiskey; John J O'Connor
Journal:  Exp Physiol       Date:  2005-06-08       Impact factor: 2.969

4.  TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients.

Authors:  T W Huizinga; R G Westendorp; E L Bollen; V Keijsers; B M Brinkman; J A Langermans; F C Breedveld; C L Verweij; L van de Gaer; L Dams; J B Crusius; A García-Gonzalez; B W van Oosten; C H Polman; A S Peña
Journal:  J Neuroimmunol       Date:  1997-02       Impact factor: 3.478

5.  TNF-alpha polymorphisms in multiple sclerosis: no association with -238 and -308 promoter alleles, but the microsatellite allele a11 is associated with the disease in French patients.

Authors:  G Lucotte; C Bathelier; G Mercier
Journal:  Mult Scler       Date:  2000-04       Impact factor: 6.312

6.  Control of synaptic strength by glial TNFalpha.

Authors:  Eric C Beattie; David Stellwagen; Wade Morishita; Jacqueline C Bresnahan; Byeong Keun Ha; Mark Von Zastrow; Michael S Beattie; Robert C Malenka
Journal:  Science       Date:  2002-03-22       Impact factor: 47.728

7.  High frequency of TNF alleles -238A and -376A in individuals from northern Sardinia.

Authors:  Sebastian A Wirz; Maria C Morale; Bianca Marchetti; Alasdair M Barr; Stefano Sotgiu; Giulio Rosati; Maura Pugliatti; Maria Vittoria Sanna; Orazio Giliberto; Tamas Bartfai; Bruno Conti
Journal:  Cytokine       Date:  2004-05-21       Impact factor: 3.861

8.  Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity.

Authors:  P Rieckmann; M Albrecht; B Kitze; T Weber; H Tumani; A Broocks; W Lüer; A Helwig; S Poser
Journal:  Ann Neurol       Date:  1995-01       Impact factor: 10.422

9.  Is tumor necrosis factor-376A promoter polymorphism associated with susceptibility to multiple sclerosis?

Authors:  Marcelo A Kauffman; Dolores González Morón; Gustavo Sandoval; Roberto E Sica; Orlando Garcea; Andrés M Villa
Journal:  Medicina (B Aires)       Date:  2007       Impact factor: 0.653

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  2 in total

Review 1.  Neurogenomics in Africa: Perspectives, progress, possibilities and priorities.

Authors:  Rufus O Akinyemi; Mayowa O Owolabi; Tolulope Oyeniyi; Bruce Ovbiagele; Donna K Arnett; Hemant K Tiwari; Richard Walker; Adesola Ogunniyi; Raj N Kalaria
Journal:  J Neurol Sci       Date:  2016-05-06       Impact factor: 3.181

2.  Tumor necrosis factor-alpha polymorphism and susceptibility to multiple sclerosis in the Iranian population.

Authors:  Masoomeh Rahmanian; Mohammad Kargar
Journal:  Iran Red Crescent Med J       Date:  2014-12-27       Impact factor: 0.611

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.